Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO.
暂无分享，去创建一个
C. Leyronnas | G. Freyer | E. Hénin | M. Tod | A. Hardy-Bessard | C. Falandry | A. Sostelly | L. Chauvenet | V. Jestin-Le Tallec | S. Kirsher | C. Ligeza-poisson | S. Ramdane | Jacques Salavt | Sylvie Van-Hult | J. Vannetzel